The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
N -Acetylcysteine and Contrast-Induced Nephropathy in Primary Angioplasty
Abstract
BACKGROUND: Patients with acute myocardial infarction undergoing primary angioplasty are at high risk for contrast-medium-induced nephropathy because of hemodynamic instability, the need for a high volume of contrast medium, and the lack of effective prophylaxis. We investigated the antioxidant N-acetylcysteine for the prevention of contrast-medium-induced nephropathy in patients undergoing primary angioplasty. METHODS: We randomly assigned 354 consecutive patients undergoing primary angioplasty to one of three groups: 116 patients were assigned to a standard dose of N-acetylcysteine (a 600-mg intravenous bolus before primary angioplasty and 600 mg orally twice daily for the 48 hours after angioplasty), 119 patients to a double dose of N-acetylcysteine (a 1200-mg intravenous bolus and 1200 mg orally twice daily for the 48 hours after intervention), and 119 patients to placebo. RESULTS: The serum creatinine concentration increased 25 percent or more from baseline after primary angioplasty in 39 of the control patients (33 percent), 17 of the patients receiving standard-dose N-acetylcysteine (15 percent), and 10 patients receiving high-dose N-acetylcysteine (8 percent, P<0.001). Overall in-hospital mortality was higher in patients with contrast-medium-induced nephropathy than in those without such nephropathy (26 percent vs. 1 percent, P<0.001). Thirteen patients (11 percent) in the control group died, as did five (4 percent) in the standard-dose N-acetylcysteine group and three (3 percent) in the high-dose N-acetylcysteine group (P=0.02). The rate for the composite end point of death, acute renal failure requiring temporary renal-replacement therapy, or the need for mechanical ventilation was 21 (18 percent), 8 (7 percent), and 6 (5 percent) in the three groups, respectively (P=0.002). CONCLUSIONS: Intravenous and oral N-acetylcysteine may prevent contrast-medium-induced nephropathy with a dose-dependent effect in patients treated with primary angioplasty and may improve hospital outcome. (ClinicalTrials.gov number, NCT00237614[ClinicalTrials.gov]).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention
Rihal, C. S., Textor, S. C., Grill, D. E., Berger, P. B., Ting, H. H., Best, P. J., Singh, M., Bell, M. R., Barsness, G. W., Mathew, V., et al. (2002) · Circulation · doi:10.1161/01.cir.0000016043.87291.33 · Cited by 1,712
Acute Renal Failure After Coronary Intervention
McCullough, P. A., Wolyn, R., Rocher, L. L., Levin, R. N., & O’Neill, W. W. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00150-2 · Cited by 1,671
Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by Acetylcysteine
Tepel, M., van der Giet, M., Schwarzfeld, C., Laufer, U., Liermann, D., & Zidek, W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430304 · Cited by 1,588
Management of acute myocardial infarction in patients presenting with ST-segment elevation
VandeWerf, F. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00618-8 · Cited by 1,448
Parfrey, P. S., Griffiths, S. M., Barrett, B. J., Paul, M. D., Genge, M., Withers, J., Farid, N., & McManamon, P. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901193200303 · Cited by 1,011
Mueller, C., Buerkle, G., Buettner, H. J., Petersen, J., Perruchoud, A. P., Eriksson, U., Marsch, S., & Roskamm, H. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.3.329 · Cited by 806
Marenzi, G., Lauri, G., Assanelli, E., Campodonico, J., De Metrio, M., Marana, I., Grazi, M., Veglia, F., & Bartorelli, A. L. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.043 · Cited by 737
Self-citationBest, P. J. M., Lennon, R., Ting, H. H., Bell, M. R., Rihal, C. S., Holmes, D. R., & Berger, P. B. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01745-x · Cited by 731
The Prevention of Radiocontrast-Agent–Induced Nephropathy by Hemofiltration
Marenzi, G., Marana, I., Lauri, G., Assanelli, E., Grazi, M., Campodonico, J., Trabattoni, D., Fabbiocchi, F., Montorsi, P., & Bartorelli, A. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa023204 · Cited by 504
Self-citationAcetylcysteine for prevention of contrast nephropathy: meta-analysis
Birck, R., Krzossok, S., Markowetz, F., Schnülle, P., van der Woude, F. J., & Braun, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14189-x · Cited by 477
Kay, J., Chow, W. H., Chan, T. M., Lo, S. K., Kwok, O. H., Yip, A., Fan, K., Lee, C. H., & Lam, W. F. (2003) · JAMA · doi:10.1001/jama.289.5.553 · Cited by 434
Sadeghi, H. M., Stone, G. W., Grines, C. L., Mehran, R., Dixon, S. R., Lansky, A. J., Fahy, M., Cox, D. A., Garcia, E., Tcheng, J. E., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103623.63687.21 · Cited by 403
Acetylcysteine and contrast agent-associated nephrotoxicity
Briguori, C., Manganelli, F., Scarpato, P., Elia, P. P., Golia, B., Riviezzo, G., Lepore, S., Librera, M., Villari, B., Colombo, A., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01958-7 · Cited by 360
Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial)
Diaz-Sandoval, L. J., Kosowsky, B. D., & Losordo, D. W. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02243-3 · Cited by 350
Alonso, A., Lau, J., Jaber, B. L., Weintraub, A., & Sarnak, M. J. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.09.009 · Cited by 345
A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study
Baker, C. S. R., Wragg, A., Kumar, S., De Palma, R., Baker, L. R. I., & Knight, C. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00487-x · Cited by 340
Durham, J. D., Caputo, C., Dokko, J., Zaharakis, T., Pahlavan, M., Keltz, J., Dutka, P., Marzo, K., Maesaka, J. K., & Fishbane, S. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00673.x · Cited by 300
Acute renal failure requiring dialysis after percutaneous coronary interventions
Gruberg, L., Mehran, R., Dangas, G., Mintz, G. S., Waksman, R., Kent, K. M., Pichard, A. D., Satler, L. F., Wu, H., & Leon, M. B. (2001) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.1093 · Cited by 250
Kshirsagar, A. V., Poole, C., Mottl, A., Shoham, D., Franceschini, N., Tudor, G., Agrawal, M., Denu-Ciocca, C., Magnus Ohman, E., & Finn, W. F. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000116241.47678.49 · Cited by 238
Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity
Briguori, C. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.11.016 · Cited by 236
Marenzi, G., Lauri, G., Campodonico, J., Marana, I., Assanelli, E., De Metrio, M., Grazi, M., Veglia, F., Fabbiocchi, F., Montorsi, P., et al. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.08.002 · Cited by 191
Self-citationIs acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis
Nallamothu, B. K., Shojania, K. G., Saint, S., Hofer, T. P., Humes, H. D., Moscucci, M., & Bates, E. R. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.06.046 · Cited by 188
Webb, J. G., Pate, G. E., Humphries, K. H., Buller, C. E., Shalansky, S., Al Shamari, A., Sutander, A., Williams, T., Fox, R. S., & Levin, A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.041 · Cited by 176
Coronary Angiography and Acute Renal Failure in Diabetic Azotemic Nephropathy
Weinrauch, L. A., HEALY, R. W., LELAND, O. S., GOLDSTEIN, H. H., KASSISSIEH, S. D., LIBERTINO, J. A., TAKACS, F. J., & D’Elia, J. A. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-86-1-56 · Cited by 172
Goldenberg, I. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.11.011 · Cited by 160
Arstall, M. A., Yang, J., Stafford, I., Betts, W. H., & Horowitz, J. D. (1995) · Circulation · doi:10.1161/01.cir.92.10.2855 · Cited by 155
Evidence for the role of oxidative stress in acute ischemic heart disease: a brief review.
Dhalla, N. S., Golfman, L. S., Takeda, S., Takeda, N., & Nagano, M. (1999) · PubMed · Cited by 134
Isenbarger, D. W., Kent, S. M., & O’Malley, P. G. (2003) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.08.059 · Cited by 126
Grech, E. D., Dodd, N. J. F., Jackson, M. J., Morrison, W. L., Faragher, E. B., & Ramsdale, D. R. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)90580-9 · Cited by 99
N-acetylcysteine ameliorates renal microcirculation: Studies in rats
Heyman, S. N., Goldfarb, M., Shina, A., Karmeli, F., & Rosen, S. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00783.x · Cited by 89
SOCHMAN, J., Vrbská, J., Musilová, B., & Roček, M. (1996) · Clinical Cardiology · doi:10.1002/clc.4960190205 · Cited by 66
Carrabba, N., Santoro, G. M., Balzi, D., Barchielli, A., Marchionni, N., Fabiani, P., Landini, C. M., Scarti, L., Santoro, G., Valente, S., et al. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.07.076 · Cited by 54
N‐acetyl‐ L ‐cysteine exerts direct anti‐aggregating effect on human platelets
Anfossi, G., Russo, I., Massucco, P., Mattiello, L., Cavalot, F. L., & Trovati, M. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00815.x · Cited by 43
N-Acetylcysteine Enhances Endothelium-Dependent Vasorelaxation in the Isolated Rat Mesenteric Artery
Lopez, B. L., Snyder, J. W., Birenbaum, D. S., & Ma, X. (1998) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(98)70167-2 · Cited by 33
Cited by
Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), Authors/Task Force Members, Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,184
Authors/Task Force Members, Bassand, J.-P., Hamm, C. W., Ardissino, D., Boersma, E., Budaj, A., Fernandez-Aviles, F., Fox, K. A. A., Hasdai, D., Ohman, E. M., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm161 · Cited by 1,849
Contrast Medium-Induced Acute Kidney Injury
Sadat, U., Usman, A., Boyle, J. R., Hayes, P. D., & Solomon, R. J. (2015) · Cardiorenal Medicine · doi:10.1159/000430770 · Cited by 1,285
Abbara, S., Blanke, P., Maroules, C. D., Cheezum, M., Choi, A. D., Han, B. K., Marwan, M., Naoum, C., Norgaard, B. L., Rubinshtein, R., et al. (2016) · Journal of Cardiovascular Computed Tomography · doi:10.1016/j.jcct.2016.10.002 · Cited by 1,095
2012 Writing Committee Members, Jneid, H., Anderson, J. L., Wright, R. S., Adams, C. D., Bridges, C. R., Casey, D. E., Ettinger, S. M., Fesmire, F. M., Ganiats, T. G., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318256f1e0 · Cited by 1,090
Metadata
- Authors
- Marenzi, G., Assanelli, E., Marana, I., Lauri, G., Campodonico, J., Grazi, M., De Metrio, M., Galli, S., Fabbiocchi, F., Montorsi, P., Veglia, F., & Bartorelli, A. L.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-06-29
- Volume
- 354
- Issue
- 26
- Pages
- 2773-2782
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2130266388
- Cited by
- 611
- References
- 35
- FWCI
- 39.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.